Table 2.
Adverse life experiences and symptom-based trajectories of pain, depression, anxiety, and comorbidities.
| Coef | SE | T | Pval | R2 | Adj R2 | CI [2.5%] | CI [97.5%] | VIF | Pval_corrected | |
|---|---|---|---|---|---|---|---|---|---|---|
| ALEs and high-level symptom-based trajectories | ||||||||||
| Pain | ||||||||||
| Physical_illness_child FU1 | 0.029 | 0.009 | 3.402 | 0.001 | 0.143 | 0.094 | 0.012 | 0.046 | 5.640213 | 0.039 |
| Total ALE score FU2 | 0.022 | 0.007 | 3.024 | 0.003 | 0.025 | 0.02 | 0.008 | 0.036 | 5.111497 | 0.015 |
| Abuse and maltreatment—Factor1 | 0.023 | 0.006 | 3.570 | 0.000 | 0.025 | 0.021 | 0.010 | 0.036 | 1.860628 | 0.000 |
| Depression | ||||||||||
| Sexual_abuse | 0.023 | 0.006 | 4.120 | 0.000 | 0.097 | 0.055 | 0.012 | 0.034 | 1.209255 | 0.000 |
| BullyingBL | 0.028 | 0.006 | 4.765 | 0.000 | 0.097 | 0.055 | 0.016 | 0.039 | 1.590381 | 0.000 |
| Total ALE score FU1 | 0.016 | 0.005 | 2.934 | 0.003 | 0.016 | 0.012 | 0.005 | 0.027 | 6.084844 | 0.015 |
| Anxiety | ||||||||||
| BullyingBL | 0.034 | 0.008 | 4.513 | 0.000 | 0.111 | 0.07 | 0.019 | 0.049 | 1.590381 | 0.000 |
| Total ALE score FU1 | 0.023 | 0.007 | 3.425 | 0.001 | 0.034 | 0.031 | 0.010 | 0.037 | 6.084844 | 0.005 |
| Total ALE score FU2 | 0.018 | 0.007 | 2.677 | 0.008 | 0.034 | 0.031 | 0.005 | 0.031 | 4.457266 | 0.040 |
| ALEs and moderate-level symptom-based trajectories | ||||||||||
| Pain | ||||||||||
| BullyingFU1 | 0.060 | 0.014 | 4.300 | 0.000 | 0.111 | 0.059 | 0.033 | 0.087 | 1.419223 | 0.000 |
| Total ALE score FU1 | 0.048 | 0.014 | 3.348 | 0.001 | 0.047 | 0.043 | 0.020 | 0.076 | 8.055105 | 0.005 |
| Depression | ||||||||||
| Parents_violentFU1 | −0.035 | 0.010 | −3.349 | 0.001 | 0.085 | 0.043 | −0.056 | −0.015 | 1.892365 | 0.039 |
| Total ALE score FU3 | 0.031 | 0.009 | 3.531 | 0.000 | 0.02 | 0.017 | 0.014 | 0.048 | 4.478934 | 0.000 |
| Factor 2 | 0.019 | 0.006 | 3.023 | 0.003 | 0.021 | 0.018 | 0.007 | 0.031 | 3.706052 | 0.015 |
| Anxiety | ||||||||||
| BullyingFU3 | 0.041 | 0.012 | 3.485 | 0.001 | 0.09 | 0.048 | 0.018 | 0.063 | 1.198944 | 0.039 |
| Material, health, and emotional deprivation—Factor 2 | 0.041 | 0.010 | 4.192 | 0.000 | 0.019 | 0.016 | 0.022 | 0.061 | 3.706052 | 0.000 |
| ALEs and symptom-based trajectories of pain comorbidities | ||||||||||
| Pain–depression comorbidities | ||||||||||
| Substance abuse in the household FU2 | 0.021 | 0.006 | 3.409 | 0.001 | 0.065 | 0.019 | 0.009 | 0.033 | 1.304255 | 0.039 |
| Abuse and maltreatment—Factor1 | 0.015 | 0.004 | 3.453 | 0.001 | 0.018 | 0.014 | 0.007 | 0.024 | 1.880138 | 0.005 |
| Pain–anxiety comorbidities | ||||||||||
| Material, health, and emotional deprivation—Factor 2 | 0.015 | 0.006 | 2.662 | 0.008 | 0.019 | 0.015 | −0.004 | 0.027 | 3.635520 | 0.040 |
| Pain–depression–anxiety comorbidities | ||||||||||
| Material, health, and emotional deprivation—Factor 2 | 0.011 | 0.004 | 3.008 | 0.003 | 0.016 | 0.013 | 0.004 | 0.018 | 3.680576 | 0.015 |
The regression models for ALEs categories at all time points BL (Baseline), FU1 (Follow-up 1), FU2 (Follow-up 2), FU3 (Follow-up 3) and the high and moderate symptoms classes of pain, depression, and anxiety and comorbidities. The table reports only results that retained statistical significance after correction. For high symptom trajectories, physical illness, bullying, sexual abuse, total ALE scores, and specific factors emerged as significant for pain, depression, and anxiety. Moderate symptom trajectories revealed again that bullying, parental violence, total ALE scores, and abuse and maltreatment factor were also significant, with distinct patterns for each symptom. Pain–depression comorbidities were significantly associated with household substance abuse and abuse-maltreatment factor. Pain–anxiety comorbidities were linked to deprivation-related factors, as well as the combined pain–depression–anxiety comorbidity. These findings underscore the differentiated pathways through which ALEs contribute to comorbid symptom development. Full details and expanded analyses are provided in Supplement, http://links.lww.com/PR9/A380. In the corresponding order Coefficients, Standard Errors, T-values, P-values, R-squared, Adjusted R-squared, Confidence Intervals, VIF, and Bonferroni-corrected P-values. Age ranges for participants at each time point were 14 to 15 y (BL), with follow-ups at 16 to 17 (FU1), 18 to 19 (FU2), and 22 to 24 (FU3). Bold font indicates statistically significant P-values.
ALE, adverse life experiences; VIF, variance inflation factor.